Transitions to palliation: Two solitudes or inevitable integrations?

Current Oncology Reports

Volumn 9, Issue 4, 2007, Pages 285-289

  Rayson, Daniel ^a   McIntyre, Paul ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVANCED CANCER; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CAREGIVER; CLINICAL PRACTICE; CLINICAL TRIAL; CONSENSUS; DISTRESS SYNDROME; HEALTH CARE DELIVERY; HUMAN; LIFE EXPECTANCY; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DECISION MAKING; METASTASIS POTENTIAL; MORBIDITY; PATIENT CARE; PSYCHODYNAMICS; REVIEW; SOLID TUMOR; TREATMENT PLANNING;

CAREGIVERS; HUMANS; NEOPLASMS; PALLIATIVE CARE; PHYSICIAN-PATIENT RELATIONS; PRACTICE GUIDELINES; RISK ASSESSMENT; TERMINAL CARE; TERMINALLY ILL;

EID: 34447286894     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-007-0035-y     Document Type: Review

References (29)

1. Cummings LC, Payes JD, Cooper GS: Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer 2007, 109:718-726.
2. Escudier B, Eisen T, Stadler WM, et al.: Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 2007, 356:125-134.
3. Motzer RJ, Hutson TE, Tomczak P, et al.: Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007, 356:115-124.
4. Burris HA, Moore MJ, Anderson J, et al.: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997, 15:2403-2413.
5. Earle CC, Neville BA, Landrum MB, et al.: Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 2004, 22:315-321.
6. Murillo JR Jr, Koeller J: Chemotherapy given near the end of life by community oncologists for advanced non-small cell lung cancer. Oncologist 2006, 11:1095-1099.
7. Earle CC, Park ER, Lai B, et al.: Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol 2003, 21:1133-1138.
8. Barbera L, Paszat L, Chartier C: Indicators of poor quality end-of-life cancer care in Ontario. J Palliat Care 2006, 22:12-17.
9. Higginson IJ, Astin P, Dolan S: Where do cancer patients die? Ten-year trends in the place of death of cancer patients in England. Palliat Med 1998, 12:353-363.
10. Hunt R, Bonett A, Roder D: Trends in the terminal care of cancer patients: South Australia, 1981-1990. Aust N Z J Med 1993, 23:245-251.
11. Neutel CI, Bishop ML, Harper SD, et al.: Proportion of cancer deaths occurring in hospital, Canada, 1994-2000. Can J Public Health 2005, 96:264-268.
12. Burge F, Lawson B, Johnston G: Where a cancer patient dies: the effect of rural residency. J Rural Health 2005, 21:233-238.
13. Burge FI, Lawson B, Johnston G, et al.: Health care restructuring and family physician care for those who died of cancer. BMC Fam Pract 2005, 6:1.
14. Burge FI, Lawson B, Critchley P, et al.: Transitions in care during the end of life: changes experienced following enrolment in a comprehensive palliative care program. BMC Palliat Care 2005, 4:3.
15. Grunfeld E, Lethbridge L, Dewar R, et al.: Towards using administrative databases to measure population-based indicators of quality end-of-life care: testing the methodology. Palliat Med 2006, 20:769-777.
16. Burge F, Lawson B, Johnston G: Family physician continuity of care and emergency department use in end-of-life cancer care. Med Care 2003, 41:992-1001.
17. Trask PC, Teno JM, Nash J: Transitions of care and changes in distressing pain. J Pain Symptom Manage 2006, 32:104-109.
18. Schofield P, Carey M, Love A, et al.: 'Would you like to talk about your future treatment options?' discussing the transition from curative cancer treatment to palliative care. Palliat Med 2006, 20:397-406.
19. Slevin ML, Stubbs L, Plant HJ, et al.: Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ 1990, 300:1458-1460.
20. Matsuyama R, Reddy S, Smith TJ: Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol 2006, 24:3490-3496.
21. Burns CM, Broom DH, Smith WT, et al.: Fluctuating awareness of treatment goals among patients and their caregivers: a longitudinal study of a dynamic process. Support Care Cancer 2007, 15:187-196
22. Cherlin E, Fried T, Prigerson HG, et al.: Communication between physicians and family caregivers about care at the end of life: when do discussions occur and what is said? J Palliat Med 2005, 8:1176-1185.
23. Lawson B, Burge FI, Critchley P, et al.: Factors associated with multiple transitions in care during the end of life following enrollment in a comprehensive palliative care program. BMC Palliat Care 2006, 5:4.
24. Levy MH, Back A, Bazargan S, et al.: Palliative care. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2006, 4:776-818.
25. National Institute for Clinical Excellence: Improving supportive and palliative care for adults with cancer. Available at http://www.nice.org.uk. Accessed January 29, 2006.
26. Canadian Strategy for Cancer Control: Palliative Care Working Group Report 2002. http://www.cancercontrol.org. Accessed April 25, 2007.
27. ASCO-ESMO consensus statement on quality cancer care. J Clin Oncol 2006, 24:3498-3499.
28. Bomba PA, Vermilyea D: Integrating POLST into palliative care guidelines: a paradigm shift in advance care planning in oncology. J Natl Compr Canc Netw 2006, 4:819-829.
29. Coleman EA, Parry C, Chalmers S, et al.: The care transitions intervention: results of a randomized controlled trial. Arch Intern Med 2006, 166:1822-1828.